The '''Collaborative Group on Hormonal Factors in Breast Cancer''' ('''CGHFBC''') is a group of [[scientific researcher]]s who conduct [[meta-analysis|meta-analyses]] of the worldwide [[epidemiology|epidemiological]] evidence on [[risk factor]]s for [[breast cancer]] in women. It formed in 1992.<ref name="pmid31474332" /> Their earliest publications were a 1996 meta-analysis of 54 studies on [[hormonal birth control]] and breast cancer risk<ref name="pmid8656904">{{cite journal | title = Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies | journal = Lancet | volume = 347 | issue = 9017 | pages = 1713–27 | date = June 1996 | pmid = 8656904 | doi = 10.1016/s0140-6736(96)90806-5 | s2cid = 36136756 | url = https://cris.maastrichtuniversity.nl/ws/files/1035418/guid-c493563d-afcf-440e-8781-2ebfbe99ef56-ASSET1.0.pdf| author1 = Collaborative Group on Hormonal Factors in Breast Cancer }}</ref> and a 1997 meta-analysis of 51 studies on [[menopausal hormone therapy]] and breast cancer risk.<ref name="CGHFBC1997">{{cite journal|title=Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer|journal=The Lancet|volume=350|issue=9084|year=1997|pages=1047–1059|issn=0140-6736|doi=10.1016/S0140-6736(97)08233-0|s2cid=54389746|doi-access=free}}</ref> One of their recent publications was a 2019 meta-analysis of menopausal hormone therapy and breast cancer risk based on type and timing of therapy.<ref name="pmid31474332">{{cite journal | title = Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence | journal = Lancet | volume = 394 | issue = 10204 | pages = 1159–1168 | date = September 2019 | pmid = 31474332 | pmc = 6891893 | doi = 10.1016/S0140-6736(19)31709-X | author1 = Collaborative Group on Hormonal Factors in Breast Cancer }}</ref> In 2012, the group concluded in a meta-analysis of 117 studies that the incidence of breast cancer was increased by each year younger at menarche and each year older at menopause.<ref>{{cite journal|title=Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies|journal=The Lancet Oncology|volume=13|issue=11|year=2012|pages=1141–1151|issn=1470-2045|doi=10.1016/S1470-2045(12)70425-4|pmc=3488186 |pmid=23084519|doi-access=free|author1=Collaborative Group on Hormonal Factors in Breast Cancer }}</ref>

==References==
{{Reflist}}

[[Category:Breast cancer]]
[[Category:Evidence-based medicine]]
[[Category:International scientific organizations]]
[[Category:Meta-analysis]]